Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terence A Kelly

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Immunity|September 23, 2003
A third mode of integrin antagonismTerence A Kelly
Journal of the American Society for Mass Spectrometry|December 31, 2002
Characterization of the allosteric inhibition of a protein-protein interaction by mass spectrometryWalter Davidson, Jerry L Hopkins, Deborah D Jeanfavre, et al.
European Journal of Pharmacology|February 21, 2006
An orally active, primate selective antagonist of LFA-1 inhibits delayed-type hypersensitivity in a humanized-mouse modelMaret J Panzenbeck, Deborah D Jeanfavre, Terence A Kelly, et al.
Molecular Cell|February 10, 2007
Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferaseStefan Kubicek, Roderick J O'Sullivan, E Michael August, et al.
Journal of Immunological Methods|June 12, 2003
Small molecule LFA-1 antagonists compete with an anti-LFA-1 monoclonal antibody for binding to the CD11a I domain: development of a flow-cytometry-based receptor occupancy assayJoseph R Woska, Kathleen Last-Barney, Robert Rothlein, et al.
Journal of Medicinal Chemistry|October 16, 2004
Second-generation lymphocyte function-associated antigen-1 inhibitors: 1H-imidazo[1,2-alpha]imidazol-2-one derivativesJiang-Ping Wu, Jonathan Emeigh, Donghong A Gao, et al.
Journal of Medicinal Chemistry|May 12, 2006
Evolution of the thienopyridine class of inhibitors of IkappaB kinase-beta: part I: hit-to-lead strategiesTina Morwick, Angela Berry, Janice Brickwood, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2009
The discovery of thienopyridine analogues as potent IkappaB kinase beta inhibitors. Part IIJiang-Ping Wu, Roman Fleck, Janice Brickwood, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Immunity|September 23, 2003
A third mode of integrin antagonismTerence A Kelly
Journal of the American Society for Mass Spectrometry|December 31, 2002
Characterization of the allosteric inhibition of a protein-protein interaction by mass spectrometryWalter Davidson, Jerry L Hopkins, Deborah D Jeanfavre, et al.
European Journal of Pharmacology|February 21, 2006
An orally active, primate selective antagonist of LFA-1 inhibits delayed-type hypersensitivity in a humanized-mouse modelMaret J Panzenbeck, Deborah D Jeanfavre, Terence A Kelly, et al.
Molecular Cell|February 10, 2007
Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferaseStefan Kubicek, Roderick J O'Sullivan, E Michael August, et al.
Journal of Immunological Methods|June 12, 2003
Small molecule LFA-1 antagonists compete with an anti-LFA-1 monoclonal antibody for binding to the CD11a I domain: development of a flow-cytometry-based receptor occupancy assayJoseph R Woska, Kathleen Last-Barney, Robert Rothlein, et al.
Journal of Medicinal Chemistry|October 16, 2004
Second-generation lymphocyte function-associated antigen-1 inhibitors: 1H-imidazo[1,2-alpha]imidazol-2-one derivativesJiang-Ping Wu, Jonathan Emeigh, Donghong A Gao, et al.
Journal of Medicinal Chemistry|May 12, 2006
Evolution of the thienopyridine class of inhibitors of IkappaB kinase-beta: part I: hit-to-lead strategiesTina Morwick, Angela Berry, Janice Brickwood, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2009
The discovery of thienopyridine analogues as potent IkappaB kinase beta inhibitors. Part IIJiang-Ping Wu, Roman Fleck, Janice Brickwood, et al.
Pageof 1